好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

AAN Advanced Practice Provider Neurology 好色先生 Series 2021 | APP2 - Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder: An Overview

Thursday 09/16/21
12:00 PM - 01:00 PM EDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Calli L. Cook, DNP, FNP-C, FAAN, Robert D. Brown, Jr., MD, MPH, FAAN
Multiple Sclerosis
Upon completion of this course, participants should be able to describe clinical presentation of NMOSD; discuss diagnostic criteria for NMOSD; compare and contrast clinical features of NMOSD with common diseases that mimic NMOSD; be familiar with the imaging characteristics of NMOSD; and discuss novel treatment options for NMOSD.
1.00 CME credit
Didactic, Other

Program Materials

Event Timeline
12:00 PM - 01:00 PM EDT Speaker Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder: An Overview
Bryan D. Walker, PA, Neeta Garg, MD
Faculty Disclosures
Robert D. Brown, Jr., MD, MPH, FAAN Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Craig H Neilsen Foundation. The institution of Dr. Brown has received research support from National Institutes of Health/NINDS. Dr. Brown has received publishing royalties from a publication relating to health care.
Neeta Garg, MD Dr. Garg has nothing to disclose.
Bryan D. Walker, PA Mr. Walker has received personal compensation for serving as an employee of EMD Serono.
Calli L. Cook, DNP, FNP-C, FAAN Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Cook has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer . Dr. Cook has a non-compensated relationship as a Board Member with Alliance for Patient Access that is relevant to AAN interests or activities.